Mednet Logo

How should Dato-DXd be managed in the absence of necessary resources for ocular exams and referrals?

What is the ideal timing and frequency of referrals for exams? What is the bare minimum if access is limited?
Community PollStarted

What supportive care measures do you use to mitigate ocular toxicity with Dato-Dxd?

119 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet Member
Medical Oncology · Massachusetts General Hospital
Answered on

We typically send patients for baseline slit-lamp exams prior to the start of Dato-DXd. If these resources are not available, telemedicine with slit-lamp biomicroscopic photography, as well as community screening resources, can be considered. Patients should still be educated on symptoms that would ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Cleveland Clinic Taussig Cancer Institute
Answered on

Ocular surface events (OSE) included events such as dry eye, increased lacrimation, blurry vision, conjunctivitis, and keratitis in the Dato-DXd studies. In TROPION-PanTumor01, any grade OSEs occurred in 17 (41.5%) HR+/HER2- breast cancer (10 [24.4%] dry eye), 16 (36.4%) triple negative breast cance...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Dana-Farber Cancer Institute and Brigham and Women's Hospital
Answered on · Updated on

In an ideal world, baseline eye exams should be performed before starting treatment and completed every three treatment cycles thereafter. Annual ophthalmologic exams and ocular exams at the time of symptom onset are necessary. However, preventive/prophylactic measures can help to mitigate the toxic...

Join for free or sign in to see the full answer